Replies to post #13066 on Momenta Pharmaceuticals, Inc. (MNTA)

[DFRAI]

Their biosimilar program is not dead

Enoxaparin - approved
Copaxone - should be approved
Humira - on track

Orencia on the table for additional partnering....

I think they validated their technology. And yes,things do not remain constant

Hope you sold this morning at 10.60 price